Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 2371 AL 2385

The Heme Oxygenase/Biliverdin Reductase System and Its Genetic Variants in Physiology and Diseases

Mancuso C.

Antioxidants (Basel). 2025 Feb 6;14(2):187. doi: 10.3390/antiox14020187.

The Place of Local Field Potentials in Deep Brain Stimulation Programming for Parkinson's Disease: A Review

Leung CHS, Simpson HD, Thyagarajan D.

Brain Sci. 2025 Jan 25;15(2):116. doi: 10.3390/brainsci15020116.

Mitochondrial Dysfunction in Neurodegenerative Diseases: Mechanisms and Corresponding Therapeutic Strategies

Meng K, Jia H, Hou X, Zhu Z, Lu Y, Feng Y, Feng J, Xia Y, Tan R, Cui F, Yuan J.

Biomedicines. 2025 Jan 31;13(2):327. doi: 10.3390/biomedicines13020327.

The Advances in Antipsychotics-Induced Dyskinesia Rodent Models: Benefits of Antioxidant Supplementation

Velickovic U, Selakovic D, Jovicic N, Mitrovic M, Janjic V, Rosic S, Randjelovic S, Milovanovic D, Rosic G.

Biomedicines. 2025 Feb 18;13(2):512. doi: 10.3390/biomedicines13020512.

The Role of the Claustrum in Parkinson's Disease and Vascular Parkinsonism: A Matter of Network?

Zedde M, Quatrale R, Cossu G, Sette MD, Pascarella R.

Life (Basel). 2025 Jan 26;15(2):180. doi: 10.3390/life15020180.

Targeting Ferroptosis in Parkinson's: Repurposing Diabetes Drugs as a Promising Treatment

Duță C, Muscurel C, Dogaru CB, Stoian I.

Int J Mol Sci. 2025 Feb 11;26(4):1516. doi: 10.3390/ijms26041516.

An Update on Neuroaging on Earth and in Spaceflight

Kuznetsov NV, Statsenko Y, Ljubisavljevic M.

Int J Mol Sci. 2025 Feb 18;26(4):1738. doi: 10.3390/ijms26041738.

Chemosensory Impairments and Their Impact on Nutrition in Parkinson's Disease: A Narrative Literature Review

Alia S, Andrenelli E, Di Paolo A, Membrino V, Mazzanti L, Capecci M, Vignini A, Fabri M, Ceravolo MG.

Nutrients. 2025 Feb 13;17(4):671. doi: 10.3390/nu17040671.

Future Perspectives of NMDAR in CNS Disorders

Capó T, Rebassa JB, Raïch I, Lillo J, Badia P, Navarro G, Reyes-Resina I.

Molecules. 2025 Feb 14;30(4):877. doi: 10.3390/molecules30040877.

Viruses and the Brain-A Relationship Prone to Trouble

Mielcarska MB, Rouse BT.

Viruses. 2025 Jan 31;17(2):203. doi: 10.3390/v17020203.

A framework to standardize gait study protocols in Parkinson's disease

Mancini M, Hausdorff JM, Pelosin E, Bonato P, Camicioli R, Ellis TD, Klucken J, Gifford L, Fasano A, Nieuwboer A, Kopil C, Klapper K, Kirsch L, Dexter DT, Fuest R, Miller V, Asis A, Müller ML, Stephenson D, Mirelman A.

J Parkinsons Dis. 2025 Feb;15(1):129-139. doi: 10.1177/1877718X241305626. Epub 2025 Feb 25.

Effects of exercise training on the nigrostriatal glutamatergic pathway and receptor interactions in Parkinson's disease: a systematic review

Ishaq S, Shah IA, Lee SD, Wu BT.

Front Aging Neurosci. 2025 Feb 11;17:1512278. doi: 10.3389/fnagi.2025.1512278. eCollection 2025.

Mesdopetam for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease: A Randomized Phase 2b Trial

Antonini A, O'Suilleabhain P, Stocchi F, Landström J, Waters S, Sonesson C, Tedroff J.

Mov Disord Clin Pract. 2025 Jun;12(6):796-806. doi: 10.1002/mdc3.70004. Epub 2025 Feb 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias